◈ Nootpedia
Compact view
Research pass: thorough Pharmaceutical · Oral OPTIONAL-ADD HIGH

Propranolol

Extended Research
◈ Extended Research ◈

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

▸ Our verdict OPTIONAL-ADD HIGH

For Dylan-archetype, propranolol is a near-ideal PRN tool for sales calls, public speaking, sparring nerves, and pitch-style high-stakes events — A-tier evidence for performance anxiety, no sedation, no cognitive blunting, ~$10-20/mo Rx, and stack-clean with V4. The verdict is OPTIONAL-ADD (not PRIMARY-PICK) only because Dylan's actual performance-anxiety load is unclear and many days don't need it; verdict would upgrade to STRONG-CANDIDATE PRN if he confirms 2-4× per week pitch/sales-call use, or downgrade to SKIP-FOR-NOW if a 4-week trial shows no perceptible delta vs L-theanine + breath protocol on similar events. AVOID for endurance/aerobic training days regardless.

Research pass: thorough
▸ Decision matrix by user profile Per-archetype
  • Dylan### 20-30, brain-priority, high cognitive workload (Dylan-archetype) OPTIONAL-ADD PRN. Propranolol is a near-ideal tool for the specific use cases Dylan has — sales calls, public speaking, sparring nerves, exam-like evaluations — where somatic anxiety is the limiter and cognitive sharpness must remain intact. The objection is just that it's not a daily compound, so it gets OPTIONAL-ADD rather than STRONG-CANDIDATE. Hard rule
    —

    avoid on aerobic/conditioning training days. For a 20-year-old with no cardiac/asthma risk factors, the side-effect profile is benign at PRN dosing and the upside for high-stakes performance is large. ### 30-50, executive maintenance OPTIONAL-ADD PRN. Same use case as Dylan-archetype but the population skews toward higher cumulative event-load (more board meetings, more presentations). PRN cadence often increases. Watch for resting HR drift and consider whether the volume warrants chronic baseline anxiolytic instead. ### 50+, mild cognitive decline OPTIONAL-ADD with caution. Propranolol is generally tolerated in older adults but bradycardia risk is higher, fall risk from orthostatic hypotension is non-trivial, and chronic high-dose use has weak associations with cognitive complaints in some elderly cohorts. Use lowest effective PRN dose; ECG before chronic use. ### Anxiety-prone (general anxiety, social anxiety baseline) OPTIONAL-ADD as PRN tool, not a primary treatment. For somatic-driven anxiety (the "I feel my heart racing" loop), propranolol is excellent. For cognitive anxiety (rumination, worry), it's marginal — pair with CBT, l-theanine, and possibly an SSRI baseline if the anxiety is daily-functional-impairing. Propranolol is best as a complement, not the foundation. ### High athletic load, tested status (WADA) SKIP for performance days; PROHIBITED in some sports. Propranolol is on the WADA prohibited list in specific sports (archery, shooting, billiards, darts, golf, some auto sports) where the tremor-suppression effect confers performance advantage. It is NOT prohibited in MMA/combat sports or general endurance sports, but for tested athletes, check the current WADA list specific to your sport. For Dylan (untested), WADA status is irrelevant. For any sport with cardio demand, skip on competition/training days regardless of WADA status — the max-HR cap is a real performance penalty. ### Sleep-disordered NEUTRAL. Propranolol is generally sleep-neutral; some users report vivid dreams or insomnia at chronic high doses. PRN evening dosing is fine for most people. Not a sleep aid. ### Recovery-focused (post-injury, post-illness) SKIP for routine use. No recovery-relevant mechanism. Propranolol's β2 blockade may slightly impair muscle glycogen replenishment and possibly blunt the adaptive sympathetic response to training — both reasons to avoid in a recovery context. ### Strength/anabolic-focused SKIP. Mild β2 blockade may modestly reduce skeletal-muscle protein synthesis and lipolysis. Not a meaningful penalty at PRN doses but no reason to use during a hypertrophy/strength-focused phase. ### Performance anxiety / public speaking specialty PRIMARY-PICK PRN. This is the indication propranolol exists for in the off-label nootropic/performance literature. A-tier evidence, high reliability, low side-effect bill, low cost, easy sourcing. If the question is "what should I take for stage fright," propranolol is the answer. ### PTSD with reconsolidation-protocol candidacy EMERGING TOOL. Brunet protocol is real, mechanism is sound, but execution requires a clinical setting (the reactivation-narrative session is the active ingredient — propranolol alone outside of the protocol does not produce the reconsolidation effect). Not a self-administered tool for PTSD. Consider for clinical referral if a patient/Dylan ever needs it.

▸ Subjective experience (deep)

Onset: ~30 min you feel the body unclench; ~45-60 min the effect is full. Heart rate at rest drops ~5-10 bpm; under stimulation (right before walking on stage, before clicking "join meeting") it drops ~15-25 bpm vs unmedicated baseline. The familiar pre-event tachycardia spike just doesn't happen.

Peak (60-120 min):

  • Steady voice. No tremor, no shake, no quaver. This is the dominant subjective signature for public speakers.
  • Steady hands. Pen, microphone, putter — no fine tremor.
  • No sweat surge. Less palmar sweating, less forehead sweat.
  • Mentally clear. No drowsiness, no fog, no slowness. Word retrieval, working memory, reasoning all feel intact. This is why propranolol beats benzodiazepines for performance — you don't trade competence for calm.
  • Mildly disengaged from the panic loop. The body isn't sending the "you should be terrified" signal upstream, so the cognitive chatter that was riding the somatic surge gets quieter on its own. Some users describe this as feeling slightly emotionally muted or "flat" — a real but minor effect.
  • Cold extremities possible. Reduced peripheral perfusion; hands and feet can feel cold or slightly tingly. Usually mild.

Taper (3-5 hr):

  • Effect fades smoothly. No rebound at single PRN doses.
  • HR returns to baseline over 4-6 hr.

End (5-6 hr post-dose):

  • Back to baseline. No hangover, no carry-over, no next-day residue.

What it does NOT do:

  • Doesn't make you "not care" — you still want the outcome, you still feel the stakes, the body just isn't screaming.
  • Doesn't sedate. You can drive, do calculus, run a meeting.
  • Doesn't blunt motivation or drive.
  • Doesn't cause euphoria, dysphoria, or any noticeable mood shift at PRN doses.
  • Doesn't fix social anxiety in the cognitive/relational sense — if your anxiety is "I don't know what to say," propranolol won't write a script for you. It only fixes the somatic feedback loop. For combined cognitive-somatic anxiety, propranolol gets you the somatic half and L-theanine + practice gets you the rest.

Variability: Effect is highly reliable for somatic symptoms. Subjective anxiety reduction varies more — works best for people whose anxiety is driven by somatic symptoms (the "I feel my heart racing → I'm freaking out" feedback loop). Less effective for people with primarily cognitive anxiety (intrusive thoughts, rumination) where the body isn't the trigger.

▸ Tolerance + cycling deep dive
  • Tolerance buildup at PRN single-event dosing: minimal. Each event is a fresh exposure and the pharmacology is competitive-receptor-blockade — no receptor desensitization at PRN cadence.
  • Tolerance at chronic dosing: β-receptor upregulation occurs over weeks of daily use, which is why abrupt cessation produces rebound. Not relevant for PRN use.
  • Recommended cycle: none — PRN as needed, no cycling protocol.
  • Reset protocol: not applicable.
  • Frequency ceiling: Reasonable upper bound for PRN use is roughly 3-5 events per week. Above that, you're effectively in chronic-low-dose territory and should consider whether the underlying anxiety load warrants a different approach (CBT, SSRI baseline, lifestyle intervention).
▸ Stacking deep dive

Synergistic with

  • l-theanine 200 mg: Co-administer at the same time for an additive layer of calm. L-theanine acts on the GABA/glutamate axis (some α-wave / mild GABA-A modulation, glutamate buffering) — orthogonal mechanism to propranolol's adrenergic blockade. Net: better subjective calm without sedation. This is the standard "stage-fright stack" used by speakers who don't want full pharmacology.
  • practice + structured pre-event routine. Propranolol works best as a backstop for a well-rehearsed, well-prepared event. It doesn't substitute for prep — it lets your prep show through without somatic interference.
  • breath-work / box breathing pre-event. Vagal-tone shift adds to the parasympathetic effect.

Avoid stacking with

  • armodafinil same-day (Dylan stack flag): Armodafinil is a moderate CYP2C19 inhibitor and a weak CYP1A2 inducer. Propranolol is metabolized via CYP2D6 (primary) and CYP1A2 + CYP2C19 (secondary). Net effect of armodafinil on propranolol: modestly raised exposure, perhaps 20-40% higher AUC. Not catastrophic but means for Dylan, dose 10 mg propranolol if armodafinil is on board, not 20 mg, especially for the first stacked-day test. See drug interactions.
  • modafinil same-day: Same logic, slightly weaker effect. Same dose-down rule advisable.
  • other beta-blockers — redundant.
  • calcium channel blockers (verapamil, diltiazem) — additive bradycardia and AV-conduction depression. Not relevant for Dylan but a hospital-emergency-department flag.
  • clonidine — additive bradycardia and rebound-hypertension complication if either is withdrawn. Not relevant.
  • MAOIs — theoretical risk, rare clinical issue.
  • ergot alkaloids — peripheral vasoconstriction additive.
  • insulin/sulfonylureas (not relevant to Dylan) — masks hypoglycemia symptoms.
  • alcohol heavy use same-day — additive hypotension; mild. Not relevant for Dylan (zero alcohol).

Neutral / safe co-administration

  • All of Dylan's V4 stack: DHA, magtein, citicoline, NAC, phosphatidylserine, magnesium glycinate, curcumin phytosome, rhodiola, l-theanine, glycine/tryptophan, D3+K2, beta-alanine, vitamin C — no clinically relevant interactions
  • Creatine — fine
  • Caffeine — fine, but the stack is somewhat self-cancelling (caffeine raises HR via adenosine antagonism; propranolol blocks the downstream adrenergic effect). Net is calmer-than-caffeine-alone, which is sometimes the point.
  • Adamax / Semax / Selank intranasal peptides — fine, no known interaction
  • Cerebrolysin IM — fine
  • BPC-157 / TB-500 — fine
  • Selegiline 1-2.5 mg AM (V5 plan) — fine; selegiline at MAO-B-selective doses doesn't interact meaningfully with beta-blockade
  • Bromantane — fine; adrenergic profile of bromantane is largely D2/D3 + 5-HT, minimal direct adrenergic
  • Agmatine — fine; orthogonal mechanism
  • Pramiracetam, sulbutiamine, alpha-GPC — fine
▸ Drug interactions deep dive

Propranolol's CYP profile:

  • Substrate: CYP2D6 (primary, ~80% of clearance), CYP1A2 (secondary), CYP2C19 (minor pathway).
  • Inhibitor: Mild inhibition of CYP1A2 at high chronic doses; not clinically meaningful at PRN doses.
  • Inducer: None.

Specific interactions worth flagging for Dylan:

  • Armodafinil (V5 plan, daily 75-150 mg) — CYP2C19 inhibition raises propranolol exposure. Armodafinil is a moderate CYP2C19 inhibitor. The CYP2C19 pathway is a minor secondary clearance route for propranolol but the inhibition is real and was flagged in the armodafinil compound file. Practical effect: ~20-40% higher propranolol AUC when armodafinil is on board. For PRN performance dosing, the mitigation is dose-down to 10 mg propranolol on armodafinil days rather than 20 mg.
  • Modafinil (V5 daily-driver plan) — same CYP2C19 dynamic, slightly weaker. Same mitigation: 10 mg propranolol if modafinil is on board.
  • CYP2D6 inhibitors raise propranolol exposure dramatically — fluoxetine, paroxetine, bupropion, quinidine, diphenhydramine. Not currently on Dylan's stack but bupropion is on the V5 conditional list. If bupropion enters Dylan's stack, dose-down propranolol to 10 mg PRN strictly.
  • CYP1A2 inducers reduce propranolol exposure — heavy smoking (tobacco), char-grilled food (mild). Not relevant for Dylan.
  • NSAIDs can blunt the antihypertensive effect — not relevant for PRN performance use.
  • Antacids — separate doses by 2 hr; aluminum/magnesium antacids reduce propranolol absorption.

No interactions with:

  • Most peptides (BPC-157, TB-500, Cerebrolysin, Adamax, Semax, Selank)
  • Most racetams (pramiracetam, piracetam, oxiracetam)
  • Vitamin/mineral supplements
▸ Pharmacogenomics
  • CYP2D6 polymorphism — most clinically relevant. ~7% of Caucasians are CYP2D6 poor metabolizers (PMs). PMs have substantially higher propranolol exposure (2-4× AUC) at any given dose. Effect: lower starting dose appropriate for PMs (5-10 mg PRN). Conversely, ~3% are ultrarapid metabolizers (UMs) and may need higher doses. Action item for Dylan: Once 23andMe results (June 2026) are run through Promethease/GeneSight, check CYP2D6 status. If PM, start at 5-10 mg PRN; if UM, 20-40 mg PRN may be appropriate.
  • *CYP1A2 1F variant — common, increases enzyme inducibility. Mild effect on propranolol clearance; less clinically significant than CYP2D6 status.
  • CYP2C19 polymorphism — *2 and *3 = poor metabolizer (~3% Caucasians); *17 = ultrarapid. Minor secondary pathway for propranolol; effect on exposure is small unless combined with CYP2D6 PM status (then compounded).
  • β1 receptor (ADRB1) Arg389Gly polymorphism — Arg389 carriers have stronger β1 response to propranolol; clinically modest, mostly studied in heart-failure/hypertension cohorts, not in performance anxiety.
  • No HLA association for any meaningful adverse reaction; standard surveillance applies.
▸ Sourcing deep dive
Path Vendor Cost Reliability Notes
US Rx (generic propranolol IR 10/20/40/80 mg tabs) GoodRx + local pharmacy (CVS, Walgreens, Costco) ~$4-15 for 30× 20mg tabs cash; covered by most insurance High (FDA supply chain) Telehealth Rx easy — Klarity, Sesame, Hims, traditional GP all prescribe; off-label PRN performance anxiety is a recognized indication
US Rx via telehealth (off-label, performance anxiety) Sesame Care, Klarity, Hims, Maven $30-50 visit fee, $5-15 Rx High Dylan should specifically request "propranolol IR 10 mg or 20 mg, dispense 30, take 1 PRN before performance events." Most providers prescribe without resistance — this is a routine off-label request.
US Rx via primary care Existing GP Insurance copay High If Dylan has a GP relationship, easier than telehealth. Low-controversy ask.
Canadian/UK/AU Rx International pharmacy (gray-market) Not necessary N/A US Rx access is so trivial there's no reason to gray-market this one

Strategic note for Dylan: This is the easiest sourcing of any V5 compound. Telehealth visit + 30 tabs of generic propranolol IR 20 mg = ~$50-80 total, lasts months at PRN cadence. Order via Sesame Care or similar telehealth, request "propranolol immediate-release 10 mg or 20 mg, 30 count, PRN before performance events." Take a 10 mg test dose at home before relying on it for a real event.

▸ Biomarkers to track (deep)

Baseline (before starting)

  • Resting HR (Oura) — 14-day average baseline
  • Resting BP cuff — 3-reading average baseline
  • Max HR during conditioning workout — for athletic-impact context
  • HRV overnight (Oura) — 14-day baseline
  • Asthma history check — any history of childhood asthma, wheezing, exercise-induced bronchospasm? If yes, dose extra cautiously and have a rescue inhaler available for first test dose.
  • ECG — not necessary for PRN use in healthy 20-year-old; necessary if migrating to chronic dose.

During use (PRN cadence)

  • Subjective effect log per dose: dose, timing, event, HR delta, voice/hand steadiness, side effects, overall usefulness 1-10. Build a 5-10 event dataset to confirm the tool is doing what you want.
  • HR during event (Oura): confirm propranolol is producing the expected ~10-20 bpm reduction at peak adrenergic stimulus.
  • Resting HR drift: if PRN frequency creeps above 3-4×/week, watch for any baseline resting HR drift from frequent re-exposure.

Post-use (single PRN)

  • No specific post-dose tracking needed beyond the effect log.
▸ Controversies / open debates Live debate

1. Reconsolidation literature replication. The Brunet propranolol-reconsolidation work for PTSD is mechanistically attractive and clinically promising, but the high-quality replication outside Brunet's lab is still limited. The 2024-2025 trials (Wood et al., Thierrée et al.) extend the indication but n is still small. Skeptics (Kindt lab boundary-condition studies, some null trials in 2014-2020) argue the effect is real but more parameter-sensitive than enthusiasts claim. Honest read: B-tier evidence, deserves more replication, not yet first-line for PTSD but legitimate for treatment-resistant cases in a clinical setting.

2. Cognitive-impairment-on-memory-consolidation tasks in healthy users. Some studies (Rogers et al. 2004, others) show propranolol mildly impairs episodic memory consolidation in healthy volunteers when administered before learning. This is mechanistically consistent with the central noradrenergic role in memory consolidation. Practical implication for Dylan: don't take propranolol before a learning-heavy task (studying, complex training session) where you want to remember the content. Public speaking and sparring nerves don't have a meaningful learning component during the event, so this isn't a problem there.

3. Beta-blockers and depression risk — historically over-stated. Older clinical lore held that propranolol increases depression risk via central monoamine effects. Recent meta-analyses (Riemer et al. 2021, Lancet Psychiatry) suggest the effect is small-to-null in non-cardiac populations. Don't dismiss it but don't over-weight it.

4. Long-term cognitive concerns at chronic use. A few observational studies have flagged associations between long-term beta-blocker use and mild cognitive complaints in elderly cohorts. Confounding is severe (patients on chronic beta-blockers have cardiovascular disease, which itself is a cognitive risk factor). For PRN use, this is not a concern. For chronic use over years, the literature is murky and not actionable.

5. Asthma hard-line vs nuanced approach. Old teaching: non-selective beta-blockers absolutely contraindicated in asthma. Newer view: cardio-selective β1-blockers (metoprolol, atenolol) can be used cautiously in mild asthma; non-selective propranolol still risky. For Dylan: no asthma history reported, so this is not a concern, but always self-screen at first test dose.

6. Performance anxiety as a "real" indication. Some critics argue propranolol is over-prescribed for performance anxiety and that CBT, exposure, and skill-building should be primary. The honest answer: both are right. Propranolol is a high-leverage tool for acute high-stakes events; it's not a substitute for the underlying skill-building. Use it as a backstop, not a foundation.

7. WADA-class beta-blocker implications. Propranolol is on the WADA prohibited list specifically for tremor-sensitive sports (archery, shooting, etc.) but not for combat sports or endurance. The reason for sport-specific listing is it directly improves performance in tremor-sensitive sports. For MMA, it's not banned but it would hurt cardio performance — so the sport-by-sport asymmetry maps to mechanism-by-mechanism asymmetry.

8. Beta-blocker for healthy young adults — appropriate or over-medicalization? Defensible debate. Propranolol PRN at low doses for high-stakes events in an otherwise healthy 20-year-old is a low-risk, high-leverage intervention with a 50-year track record in classical music and surgery. The over-medicalization critique applies more to chronic baseline use without underlying pathology. Verdict: appropriate as PRN tool; questionable as chronic baseline.

▸ Verdict change log
  • 2026-05-05 — Initial verdict: OPTIONAL-ADD PRN (high confidence). Established as a near-ideal PRN tool for Dylan's specific high-stakes-event use cases (sales calls, public speaking, sparring nerves, exam-like evaluations) with A-tier evidence for the indication, no sedation, easy US Rx sourcing, low cost, and clean stacking with V4. Hard avoid for endurance/aerobic training days. Verdict pending real-world PRN dosing data (5-10 events) to confirm subjective utility delta vs L-theanine + breath protocol alone.
▸ Open questions / gaps Open
  • What is Dylan's actual PRN frequency? Sales calls + public speaking + sparring nerves = 1× per week? 3× per week? This drives whether OPTIONAL-ADD is the right verdict or whether STRONG-CANDIDATE PRN is warranted. Action: log 4 weeks of high-stakes event frequency before ordering.
  • L-theanine + breath alone — is propranolol additive or redundant? No formal head-to-head. Recommend testing on alternating events (event 1: L-theanine + breath; event 2: + 20 mg propranolol; compare).
  • CYP2D6 status (June 2026 23andMe results) will inform starting dose — PM means 5-10 mg PRN; UM means 20-40 mg PRN.
  • Does propranolol affect motor learning during sparring drilling? Theoretically possible (central NE consolidation role) but no specific data. Avoid on heavy technique-acquisition days as a precaution.
  • Reconsolidation use case for Dylan? Not currently indicated — no PTSD diagnosis, no specific traumatic memory targets. If subconcussive-impact emotional residue ever became a target (it isn't currently), Brunet protocol could be considered in clinical setting.
  • Long-term cognitive implications of even occasional PRN use over decades? Unstudied. Likely benign at PRN cadence but unfalsified.
▸ Sources (full, with our context)
Back to compact view